Releases & Statements

The Senior Care Pharmacy Coalition appreciates the opportunity to comment on the Part D provisions of the Draft Call Letter titled, “Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 Draft Call Letter.” The Draft Call Letter includes several proposals affecting beneficiary access to medications under the program and the ability of long-term care (LTC) pharmacies to dispense those medications and provide related consultative services…Read More

National Long Term Care (LTC) Pharmacy Group Urges Congress to Follow 2016 Precedent by Exempting LTC Facilities from 3-Day Dose Provision…Read More.

House Judiciary Subcommittee Hearing on Drug Supply Chain Should Examine Increasingly Oligopolistic Health Care System, Efforts to Monopolize Prescription Drug Marketplace…Read More.

Report Says Policies to Disrupt PBM Oligopoly “Can Reduce the Price of Drugs Paid by Consumers”…Read More.

January 25, 2018 Via Electronic Submission: CompetitionRFI@hhs.gov John R. Graham Acting Assistant Secretary for Planning and Evaluation Department of Health and Human Services 200 Independence Avenue, S.W. Washington, D.C. 20201 Re: Response to RFI: Promoting Healthcare Choice and Competition Dear Mr. Graham: The Senior Care Pharmacy Coalition (SCPC) commends the office of the Assistant Secretary […]

National LTC Pharmacy Advocacy Group Says Congress Never Intended Clause to be Misused to Undermine Free-Market…Read More.

SCPC Also Says Conceptual “Point of Sale” Policy Solution Not Effective for LTC Pharmacies, LTC Patients as Dually-Eligible Beneficiaries Constitute High Percentage of Patient Population; CMS Authorized to Act under Medicare Part D…Read More.

Tells House Energy and Commerce Health Panel Medicare Part D Has Become Oligopolistic Market Benefitting Only PBMs and Their Conglomerates…Read More.

SCPC Praises Senate HELP Committee’s Ongoing Examination of Drug Costs, says “PBM Oligopoly Maintains Anti-Competitive Stranglehold on LTC Pharmacies and Patients Under Their Care”…Read More.